Inside our new clinical trial.
350 people. 40 states. 1 probiotic.
Share
Seed promotes DS-01, a probiotic validated in a large clinical trial for bloating and gas, offering 25% off the first month. The trial showed significant improvements in nearly 350 healthy men and women, with nearly 80% reporting minimal discomfort from constipation. Seed highlights the product's proven benefits, including less bloating, gas, and irregularity.
What the raw message shows
From the headers
- Sent with
-
Iterable
See it in the headers
In the HTML
- Built with
- Dark-mode styles
Across Seed's email
- Sends
- About 4 a week
- DMARC
-
Not enforced
Failures are monitored but still delivered.
The copy
201 words · about 1 min to read
25% Off Your First Month of DS-01® ◊
Real Relief, Rigorously Proven
DS-01® is validated in the largest probiotic clinical trial for bloating and gas.¹° That’s a whole new level of proof. | Start DS-01®
Did You Know? | Most probiotic studies are small or only include people with GI conditions. We studied nearly 350 healthy men + women across 40 states and still saw significant improvements. | Start DS-01®
IN OUR CLINICAL TRIAL, NEARLY 80% reported minimal discomfort from constipation.° | 72% reported never or rarely feeling bloated.°
Feel the DS-01® Difference | Less bloating. Less gas. Less irregularity. Time to try the proven probiotic standard.° | Start DS-01®
Citations | ¹In healthy adults, as of February 2026. | °These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. | ◊Offer expires on 8/30/2026 at 11:59 p.m. PT. Offer valid on new DS-01® one-month welcome kits, for a maximum value of $12.50. Offer cannot be combined with any other discounts or promotions.
Pioneering microbial science for human and planetary health since 2015.
This email was sent by Seed.
New York, NY10013
Seed Health, Inc. 2026
The words as text: what a screen reader can follow, and all there is when images don't load.
What the headers say
Read from the message's own headers, as it arrived.
- Came from
-
outbound153-2.iterable.com
· 159.112.240.153
Iterable's sending servers
- SPF
- Pass for mail.seed.com
- DKIM
-
- Pass signed by mail.seed.com
- DMARC
-
Pass for mail.seed.com
Policy: none, so failures would still be delivered
- Unsubscribe
-
One-click
Meets the Gmail and Yahoo rule for bulk senders.
- Complaints
-
Feedback loop set up
Mailbox providers can report spam complaints straight back to the sender.
Show all 24 headers Hide the headers
As received, minus the delivery side: the archive's own addresses show as [recipient], its mail servers as [receiver], signatures are left out and unsubscribe links trimmed to their host.
Route
- Received Identifies Iterable
- from outbound153-2.iterable.com (159.112.240.153) by [receiver] (cloudflare) id ZzfDtXFLUONc for <[recipient]>; Thu, 06 Aug 2026 00:31:39 +0000
- Received
- by 8e139f0cb60154f151da6c36c1c38986ec9be4de0e5b768334d0d5288453c23f with HTTP id 6a73d5fa00f0e79997b24008; Thu, 06 Aug 2026 00:31:54 GMT
- Return-Path
- [email protected]
Authentication
- Received-SPF Authentication result
- pass ([receiver]: domain of [recipient]@mail.seed.com designates 159.112.240.153 as permitted sender) receiver=[receiver]; client-ip=159.112.240.153; envelope-from="[recipient]@mail.seed.com"; helo=outbound153-2.iterable.com;
- Authentication-Results Authentication result
- [receiver]; dkim=pass header.d=mail.seed.com header.s=mailo header.b=NVbXasGs; dmarc=pass header.from=mail.seed.com policy.dmarc=none; spf=none ([receiver]: no SPF records found for [email protected]) smtp.helo=outbound153-2.iterable.com; spf=pass ([receiver]: domain of [recipient]@mail.seed.com designates 159.112.240.153 as permitted sender) smtp.mailfrom=[recipient]@mail.seed.com; arc=none smtp.remote-ip=159.112.240.153
Platform
- X-Mailgun-Sid
- WyI1ZTJkYSIsInNlZWRAaW5ib3hhcmNoaXZlLm9yZyIsIjgwMTUzMyJd
- X-Mailgun-Sending-Ip-Pool-Name
- Primary Iterable Shared
- X-Mailgun-Sending-Ip-Pool
- 5f5906e148d17eb79438cb88
- X-Mailgun-Sending-Ip
- 159.112.240.153
- X-Message-Id
- 95f0ed5f7c154fa4b740cdd9b7f52f60
- X-Feedback-Id
- 25044624:19182210:79091:iterable
- X-Campaign-Id
- 19182210
- X-Mailgun-Variables
- {"metadata": "{\"messageId\":\"95f0ed5f7c154fa4b740cdd9b7f52f60\",\"templateId\":25044624,\"projectId\":18601,\"campaignId\":19182210,\"recipientUserKey\":\"[recipient]\"}"}
Unsubscribe and feedback
- List-Unsubscribe
- <https://links.iterable.com/…>,<mailto:…@unsubscribe.iterable.com>
- List-Unsubscribe-Post
- List-Unsubscribe=One-Click
- Feedback-Id
- 25044624:19182210:79091:iterable
Message
- Sender
- [email protected]
- Date
- Thu, 06 Aug 2026 00:31:54 +0000
- Mime-Version
- 1.0
- Content-Type
- multipart/alternative; boundary="06003bc3ed311e0febe21f00cc4aa535cb834e9e564fc951a85716125bc0"
- Subject
- Inside our new clinical trial.
- From
- Seed <[email protected]>
- Reply-To
- [email protected]
- Message-Id
- <[email protected]>
More from Seed
All 70 emailsSimilar campaigns from other brands
Different brands running the same play. Compare any of them side by side.
Archived for reference and commentary. Seed, its logos and content are the property of their respective owners; Inbox Archive claims no affiliation and has disabled all links. If you own this content and would like it removed, get in touch.